Julie D Saba

10PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersNephrology and urologyNeurology and neuromuscular diseasesGene and molecular therapyPsychiatry (incl. psychotherapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 10, 2024
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4 + cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype.

Camila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman

|Sep 28, 2024
Factors influencing survival in sphingosine phosphate lyase insufficiency syndrome: a retrospective cross-sectional natural history study of 76 patients.

Nancy Keller, Julian Midgley, Ehtesham Khalid

|Feb 27, 2024
AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis.

Babak Oskouian, Joanna Y Lee, Shahab Asgharzadeh

|Nov 14, 2023
AAV-SPL 2.0, a Modified Adeno-Associated Virus Gene Therapy Agent for the Treatment of Sphingosine Phosphate Lyase Insufficiency Syndrome.

Ranjha Khan, Babak Oskouian, Joanna Y Lee

|Nov 13, 2022
Sphingosine phosphate lyase insufficiency syndrome: a systematic review.

Zahra Pournasiri, Abbas Madani, Fatemeh Nazarpack

|Jul 27, 2022
Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice.

Anabel S De la Garza-Rodea, Steven A Moore, Jesus Zamora-Pineda

Pageof 2

Frequent Collaborators

1 joint publications

K W Martin

1 joint publications

N Weaver

1 joint publications

K Alhasan

1 joint publications

E Gumus